Singapore-based QT Vascular has announced that it is in talks with interested third parties to seek out potential deals for its coronary products. The company said potential transactions will not involve or be in conflict with the Chocolate PTA nondrug-coated balloon, on which Medtronic has already agreed to pay $28 million for an option.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.